US Allies Fear Trump Could Soften Taiwan Stance in Xi Talks 
North Korea Vows to Expand Nuclear Arsenal Amid U.S.-Led Military Buildup 
Vietnam, U.S. Firms Plan 29 Deals Across Energy, Tech and Aviation 
Europe can’t achieve space sovereignty alone. Here’s why 
UK PM Andy Burnham Set for First Trump Meeting in New York 
Trump Eyes End to Iran War, Plans Gulf Leaders Meeting 
France Urges Faster AI Push Despite Safety Risks 
US Officials Meet Houthis in Oman Amid Yemen Offensive 
Banking scandal rocks Brazil’s politics and the country’s presidential election in October 
Iran Economic Crisis Forces Afghan Families to Return Home 
What is Zionism? The different meanings of a contested term 
Paris Talks Focus on Lebanon Army Needs as UNIFIL Exit Looms 
ICE Agent Arrested in Minneapolis Over Venezuelan Man Shooting 
Global Poll Shows Rising Trust in Institutions as US-China Leadership Support Falls 
Saudi Arabia Raises Security Alerts as Houthi Attacks Threaten Oil Routes 
US-China Experts Push AI Nuclear Safeguards to Prevent Military Escalation 
Guterres Urges Stronger Global AI Safeguards Ahead of UN Assembly 
Add as a preferred source on Google
The White House is reportedly considering former Deputy Surgeon General Erica Schwartz as its next nominee to lead the Centers for Disease Control and Prevention, according to a source familiar with ongoing internal discussions. Schwartz, who held senior public health responsibilities during President Donald Trump's first term, played a central role in managing the federal government's COVID-19 response, with oversight spanning national preparedness and interagency coordination.
Her potential nomination comes amid a period of significant leadership instability at the CDC. Former Director Susan Monarez was dismissed last August after publicly opposing vaccine policy changes championed by Health and Human Services Secretary Robert F. Kennedy Jr. Following Monarez's departure, HHS Deputy Secretary Jim O'Neill stepped in as acting CDC director before Jay Bhattacharya — currently heading the National Institutes of Health — assumed the role in February. O'Neill has since transitioned to lead the National Science Foundation.
Schwartz's prospective appointment has drawn early praise from notable public health figures across the political spectrum. Brett Giroir, who served as assistant secretary of health under the first Trump administration, highlighted her strong character and commitment to public service. Demetre Daskalakis, a former senior CDC immunization official who stepped down last year over vaccine policy disputes, credited Schwartz with demonstrating effective leadership throughout the pandemic and praised her work strengthening preparedness within the commissioned corps.
Washington Post reporter Dan Diamond also noted that Texas health commissioner Jen Shuford and senior FDA official Sara Brenner are being considered for other high-level CDC positions. Daskalakis suggested the three could form a capable leadership team, provided they are given the autonomy to operate independently of political interference from the HHS secretary.
No formal announcement regarding Schwartz's nomination has been made at this time.
